Business
Viatris Publishes Sustainability Report Showcasing 2022 Progress on Building Sustainable Access to Medicine
Supplied medicines to approximately 1 billion patients globally PITTSBURGH, May 16, 2023 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare
About this update from Viatris Inc.
[{"type":"text","content":"Supplied medicines to approximately 1 billion patients globally\nPITTSBURGH, May 16, 2023 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today published its 2022 Sustainability Report showcasing its commitment, impact and progress on building sustainable access to medicine as it continues to make a positive difference across key areas including Access and Global Health, Our People, the Environment and the Community.\nViatris supplied medicines to approximately 1 billion patients globally in 2022\"At Viatris, access is fundamental to our mission of empowering people worldwide to live healthier at every stage of life,\" said Scott A. Smith, CEO, Viatris. \"It begins with our ability to sustainably deliver high-quality medicines and health solutions at scale to people, regardless of geography or circumstance. Our commitment is both practical and aspirational and goes beyond developing, making and distributing medicines. We also work with partners to help support healthy communities, a healthy environment and resilient healthcare systems. The passion and dedication of our global workforce is remarkable and clearly on display in this report, which highlights the progress we are making to build more sustainable access to medicine across the globe.\"\nViatris is a signatory to the United Nations Global Compact (UNGC) and is committed to the Compact's 10 principles related to human rights, labor, the environment and anti-corruption and supports the Sustainable Development Goals.\nThe following are some highlights of Viatris' work and initiatives across its multiple areas of impact in 2022:\nAccess and Global Health\nSupplied medicines to approximately 1 billion patients globally. Provided treatments for approximately 8 million people living with HIV/AIDS, including almost 600,000 children.Provided >250 medicines on the World Health Organization (WHO) Essential Medicines List and 62 products on the WHO Pre-Qualification List.Promoted and strengthened healthcare professional education and training to build more resilient healthcare systems and address the burden of non-communicable diseases (NCDs), which account for nearly 75% of global deaths annually. More than 300 million patients were impacted by Viatris' outreach to healthcare professionals in 2022.Our People\nConducted our first global Viatris Voice Survey...